Suchergebnisse - "Zanichelli, Andrea"

PubPharm (193)

1

The Definition, Acronyms, Nomenclature, and Classification of Angioedema : AAAAI, ACAAI, ACARE, and APAACI DANCE Consensus

enthalten in: The Journal of allergy and clinical immunology | 2024

von Reshef, A. | Buttgereit, T. | Betschel, S. | +90

2

Comorbidities in Angioedema Due to C1-Inhibitor Deficiency : An Italian Survey

enthalten in: The journal of allergy and clinical immunology. In practice | 2024

von Zanichelli, A. | Senter, R. | Merlo, A. | +4

3

Evaluation of patient-reported outcome measures for on-demand treatment of hereditary angioedema attacks and design of KONFIDENT, a phase 3 trial of sebetralstat

enthalten in: Clinical and translational allergy | 2023

von Aygören-Pürsün, E. | Bernstein, J. | Farkas, H. | +9

4

Multicentric Observational Study on Safety and Tolerability of COVID-19 Vaccines in Patients with Angioedema with C1 Inhibitor Deficiency : Data from Italian Network on Hereditary and Acquired Angioedema (ITACA)

enthalten in: Vaccines | 2023

von Parente, R. | Sartorio, S. | Brussino, L. | +19

5

Efficacy of lanadelumab in angioedema due to acquired C1 inhibitor deficiency

enthalten in: The journal of allergy and clinical immunology. In practice | 2023

von Suffritti, C. | Sartorio, S. | Berra, S. | +3

6

An investigational oral plasma kallikrein inhibitor for on-demand treatment of hereditary angioedema : a two-part, randomised, double-blind, placebo-controlled, crossover phase 2 trial

enthalten in: Lancet (London, England) | 2023

von Aygören-Pürsün, E. | Zanichelli, A. | Cohn, D. | +23

CommentIn: Lancet. 2023 Feb 11;401(10375):413-415. - PMID 36774145

7

The international WAO/EAACI guideline for the management of hereditary angioedema-The 2021 revision and update

enthalten in: Allergy | 2022

von Maurer, M. | Magerl, M. | Betschel, S. | +56

8

Health-care associated infections surveillance in elderly patients

enthalten in: European journal of internal medicine | 2022

von Zanichelli, A. | Sgobba, S. | Merlo, A. | +1

9

Emerging drugs for the treatment of hereditary angioedema due to C1-inhibitor deficiency

enthalten in: Expert opinion on emerging drugs | 2022

von Zanichelli, A. | Montinaro, V. | Triggiani, M. | +3

ErratumIn: Expert Opin Emerg Drugs. 2022 Aug 21;:1. - PMID 35993321

10

Long-term prevention of hereditary angioedema attacks with lanadelumab : The HELP OLE Study

enthalten in: Allergy | 2022

von Banerji, A. | Bernstein, J. | Johnston, D. | +53

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[20]